South Korea’s Samsung is tamping down investor excitement about a fourth biologics manufacturing site after its Samsung BioLogics CEO suggested it could be built sooner than later. More: Samsung backtracks on executive’s remarks about timing for 4th biologics plant Source:
read moreAs one of our coverage team said as the J.P. Morgan Healthcare Conference was winding down Thursday, this first-of-the-year meeting sets the tone for months to come. And it’s certainly a great place to suss out the general biopharma mood
read moreTeva Pharmaceuticals, which has already paid half a billion dollars in U.S. penalties for having bribed foreign doctors, has now settled with authorities in Israel, but for a fraction of that amount. More: Israeli authorities cut Teva some slack as foreign
read moreMerck & Co. and Bristol-Myers Squibb have been head-to-head competitors in melanoma ever since their two immuno-oncology treatments, Keytruda and Opdivo, both won their first FDA approvals. Now, with its latest data, Keytruda can play catch-up with its rival for
read moreTesaro is issuing a safety warning for the injected version of Varubi after patients experienced anaphylaxis and anaphylactic shock. More: Tesaro's injected chemo nausea med Varubi can cause anaphylaxis, company warns Source: fierce
read moreHealth officials are urging the public make sure they are up to date with MMR vaccinations after outbreaks of measles were confirmed in five areas of England. More: PHE confirms measles outbreaks in five areas of England Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals